You are here

Identification of Borrelia burgdorferi diagnostic biomarkers in humans and nonhum

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41AI114049-01
Agency Tracking Number: R41AI114049
Amount: $591,671.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NIAID
Solicitation Number: PA10-124
Timeline
Solicitation Year: 2015
Award Year: 2014
Award Start Date (Proposal Award Date): 2014-07-15
Award End Date (Contract End Date): 2016-06-30
Small Business Information
1664 N. Virginia st., Reno, NV, 89557-0001
DUNS: 078634704
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 DAVID AUCOIN
 (775) 784-4128
 daucoin@medicine.nevada.edu
Business Contact
 DAVID MAINE
Phone: (775) 223-6169
Email: dmaine@dxdiscovery.com
Research Institution
 TULANE UNIVERSITY OF LOUISIANA
 6823 ST. CHARLES AVE
NEW ORLEANS, LA, 70118-5665
 Nonprofit college or university
Abstract
DESCRIPTION provided by applicant The number of Lyme disease cases in the US has been recently estimated by the CDC at cases year This is major public health concern Currently available diagnostics rely on detection of the antibody response serology to Borrelia burgdorferi the causative agent of Lyme disease However serological tests are not accurate during the early stages of Lyme disease Direct detection of B burgdorferi antigens within patient samples may be the only solution to an accurate early diagnosis This application focuses on validating the presence B burgdorferi VlsE protein in patient samples VlsE was recently determined to accumulate in a nonhuman primate model of Lyme disease In addition the project seeks to identify new diagnostic biomarkers for Lyme disease by utilizing a novel biomarker discovery platform termed In vivo Microbial Antigen Discovery or InMAD The overall goal is to identify multiple early Lyme disease biomarkers that can be targeted by a rapid and sensitive immunoassay PUBLIC HEALTH RELEVANCE Lyme disease LD is a serious public health concern that causes disease in an estimated US citizens annually Diagnosis of early stage Lyme disease is very challenging Currently there are no effective diagnostic tests for the direct detection of Borrelia burgdorferi available The goal of this project is to identify diagnostic biomarkers of Lyme disease and develop a prototype immunoassay

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government